RAPHAEL PHARMACEUTICAL (RAPH) Stock Overview

Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabidiol and oil. It develops product candidate for the treatment of rheumatoid arthritis, oncology indications, and hyper inflammatory syndrome inflammation related to COVID-19. Raphael Pharmaceutical Inc. is headquartered in Tel Aviv-Yafo, Israel.